Colinz Laboratories Current Share Price | Colinz Laboratories Stock Screener
COLINZ
Pharmaceuticals
Colinz Laboratories Current Stock Price Today
Live Share Price BSE
₹80.00
▼
-0.72 (-0.89%)
As of August 18, 2026, the live Colinz Laboratories share price (BSE: COLINZ) is ₹80.00, down 0.89% from the previous close, with shares trading between ₹77.00 and ₹81.12 in today's trading session, and a 52-week range of ₹39.75–₹85.92.
Analyse COLINZ share price data and track historical price performance.
Use the Colinz Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Colinz Laboratories Market Cap
₹10.22 Cr.
COLINZ P/E Ratio (TTM)
3.60
Colinz Laboratories P/B Ratio
1.15
EPS (TTM)
₹2.04
Dividend Yield
-
Debt to Equity
0.07
COLINZ 52 Week High
₹85.92
Colinz Laboratories 52 Week Low
₹39.75
Operating Margin
6.00%
Profit Margin
33.33%
COLINZ Revenue (TTM)
₹9.00
EBITDA
₹4.00
Net Income
₹3.00
Total Assets
₹13.00
Total Equity
₹10.00
Colinz Laboratories Current Share Price Chart
Track the current Colinz Laboratories share price and stock price with an interactive chart. Analyse COLINZ price trends, trading volume, historical performance, and volatility across different timeframes — the complete Colinz Laboratories stock quote in one place.
Colinz Laboratories Company Profile - Fundamental Screener
Screen Colinz Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for COLINZ shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE923C01011
Colinz Laboratories Balance Sheet Screener
Screen COLINZ balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 13 | 12 | 11 | 10 | 10 | 10 | 9 | 9 | 10 | 10 |
| Current Assets | 10 | 9 | 9 | 8 | 7 | 7 | 6 | 6 | 6 | 5 |
| Fixed Assets | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 10 | 10 | 9 | 8 | 8 | 7 | 7 | 7 | 7 | 7 |
| Share Capital | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 8 | 7 | 6 | 6 | 4 | 4 | 3 | 3 | 3 | 3 |
Colinz Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Colinz Laboratories income statement and profit fundamentals.
Analyze COLINZ quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Colinz Laboratories share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9 | 6 | 7 | 7 | 7 | 7 | 6 | 8 | 8 | 8 | 8 | 8 | 8 |
| Expenses | 6 | 6 | 6 | 7 | 7 | 6 | 6 | 7 | 7 | 8 | 8 | 8 | 7 |
| EBITDA | 4 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit % | 6.00% | 7.00% | 8.00% | 8.00% | 9.00% | 8.00% | 5.00% | 4.00% | 5.00% | 5.00% | 5.00% | 6.00% | 6.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 3 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 3 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | 11.10 | 2.04 | 1.97 | 1.93 | 1.82 | 0.74 | 0.45 | -0.01 | 0.34 | 0.65 | 0.40 | 0.21 | 0.21 |
Colinz Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen COLINZ cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -2 | 1 | 0 | 1 | 2 | 1 | 0 | 0 | 0 | 1 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| Net Cash Flow | -2 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 |
Colinz Laboratories Shareholding Pattern Screener
See Colinz Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Colinz Laboratories promoter holding and ownership changes for COLINZ on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 66.00% | 50.60% | 66.00% | 66.00% | 66.00% | 66.00% | 66.00% | 66.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 31.22% | 46.19% | 30.44% | 31.04% | 30.97% | 31.01% | 31.09% | 30.95% |
| Other Holding | 2.78% | 3.21% | 3.56% | 2.95% | 3.03% | 2.99% | 2.91% | 3.05% |
| Shareholder Count | 3,250 | 3,174 | 3,216 | 3,238 | 3,272 | 3,212 | 2,929 | 2,980 |
Colinz Laboratories Share Dividend Screener - Share Yield Analysis
Check Colinz Laboratories dividend history with payout and yield data.
View Colinz Laboratories dividend details including ex-dates and amounts for COLINZ stock.
Colinz Laboratories Stock Index Membership
See which indices include Colinz Laboratories stock.
Check COLINZ index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Colinz Laboratories Market Events Screener - Corporate Actions
Get Colinz Laboratories corporate actions including splits, bonuses, and buybacks.
Check Colinz Laboratories stock events that may affect COLINZ share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-07-30 | 2026-07-30 | Quarterly Result Announcement | NA | 0.97% |
| 2026-04-29 | 2026-04-29 | Quarterly Result Announcement | NA | 0.00% |
| 2026-01-24 | 2026-01-24 | Quarterly Result Announcement | NA | -3.42% |
| 2025-11-03 | 2025-11-03 | Quarterly Result Announcement | NA | -1.94% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | -4.86% |
| 2025-07-31 | 2025-07-31 | Quarterly Result Announcement | NA | 12.74% |
| 2025-05-16 | 2025-05-16 | Quarterly Result Announcement | NA | 13.57% |
| 2025-01-31 | 2025-01-31 | Quarterly Result Announcement | NA | -3.37% |
| 2024-10-30 | 2024-10-30 | Quarterly Result Announcement | NA | 4.60% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -8.26% |
Colinz Laboratories Competitors Screener - Peer Comparison
Screen COLINZ competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 451,555 | 38.12 | 61,674 | 12.69% | 11,565 | 34.94 |
| Divis Laboratories | 225,157 | 77.15 | 11,067 | 13.95% | 2,568 | 71.94 |
| Torrent Pharmaceuticals | 186,380 | 85.40 | 13,886 | 20.34% | 2,138 | 50.31 |
| Cipla | 115,643 | 34.91 | 29,045 | 2.24% | 3,870 | 44.50 |
| Zydus Life Science | 113,855 | 24.76 | 27,658 | 17.64% | 5,026 | 49.84 |
| Lupin | 103,289 | 18.41 | 29,039 | 26.75% | 5,356 | 34.85 |
| Dr Reddys Laboratories | 99,493 | 31.52 | 35,059 | 3.90% | 4,158 | 46.88 |
| Mankind Pharma | 98,330 | 48.34 | 14,636 | 14.85% | 1,938 | 38.70 |
| Laurus Labs | 97,698 | 89.94 | 6,868 | 22.01% | 890 | 64.41 |
| Aurobindo Pharma | 93,625 | 25.95 | 34,145 | 5.56% | 3,503 | 56.48 |
Colinz Laboratories Company Announcements - News Screener
Screen COLINZ latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-08-15 | Updates on Open Offer | - |
| 2026-08-09 | Updates on Open Offer | - |
| 2026-08-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-31 | Letter of Offer | - |
| 2026-07-31 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-30 | Outcome Of The Meeting Of Board Of Directors Was Held On Thursday 30Th July 2026 At 03:30 P.M. The Board Of Directors Discussed And/Or Approved The Following: | - |
| 2026-07-30 | Board Meeting Outcome for OUTCOME Of The Meeting Of Board Of Directors Was Held On Thursday 30Th July 2026 At 03:30 P.M. The Board Of Directors Discussed And/Or Approved The Following: | - |
| 2026-07-18 | Board Meeting Intimation for Notice Of Date Of Board Meeting Pursuant To Regulation 29(2) Of SEBI (LODR) Regulations 2015. | - |
| 2026-07-14 | Closure of Trading Window | - |
| 2026-07-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-04 | Draft Letter of Offer | - |
| 2026-07-03 | Certificate Of Non-Applicability Of Regulation 27(2) Of Chapter IV Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 For The Quarter Ended On 30Th June 2026 & Regulation 15(2)A Of Chapter IV. | - |
| 2026-07-03 | Declaration Of Non-Applicability Of Reg. 32 Of The SEBI (LODR) Regulations 2015 (Statement Of Deviation Or Variation For Proceeds Of Public Issue Rights Issue Preferential Issue QIP) For The Quarter Ended 30.06.2026. | - |
| 2026-07-03 | Declaration With Respect To Non-Applicability Of Related Party Transactions Pursuant To Regulations 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements Regulation 2015). | - |
| 2026-06-27 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Receipt Of Final Tranche Of Consideration Towards Sale Of Factory Undertaking | - |
| 2026-06-27 | Detailed Public Statement | - |
| 2026-06-18 | Announcement under Regulation 30 (LODR)-Open Offer - Updates | - |
| 2026-06-18 | Open Offer - Public Announcement | - |
| 2026-06-11 | Clarification On Significant Movement In Share Price | - |
| 2026-06-01 | Clarification sought from Colinz Laboratories Ltd | - |